Takeda Pharmaceutical Co., Ltd. (TAK)
14.39
+0.13
(+0.91%)
USD |
NYSE |
Dec 10, 15:39
Takeda Pharmaceutical Market Cap: 45.45B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 146.58B |
| Bristol Myers Squibb Co. | 104.96B |
| Johnson & Johnson | 495.66B |
| Novartis AG | 252.05B |
| Sanofi | 117.70B |
Market Cap Related Metrics
| PE Ratio | 182.61 |
| PS Ratio | 1.549 |
| Price to Book Value | 0.9413 |
| Price to Free Cash Flow | 8.325 |
| Price | 14.39 |
| Earnings Yield | 0.55% |
| Operating PE Ratio | 14.00 |
| Normalized PE Ratio | 77.12 |